Advertisement

Nutrition and Neuromuscular Disease

Chapter
Part of the Nutrition and Health book series (NH)

Abstract

Nutrition is a critical aspect of the long-term management of a patient with neuromuscular disease. Nutrition assessment with routine monitoring from diagnosis is essential. With a thorough nutrition follow-up, nutrition risk and gastrointestinal issues can be appropriately identified and dealt with as soon as possible. Complications of undernourishment or overnourishment are minimized this way, thus improving the overall picture. Attention to nutrition assessment, nutrition requirement, gastrointestinal tolerance, and pharmacological side effects is all part of optimum nutritional care and can lead to clinical improvement and improved quality of life. With appropriate nutrition intervention including macronutrient and micronutrient supplements the natural progression of the disease can be slowed and quality of life improved.

Keywords

Nutrition Neuromuscular disease Macronutrients Micro nutrients Nutritional supplements Nutraceuticals 

Abbreviations

DMD

Duchenne Muscular dystrophy

FSHMD

Facioscapulohumeral muscular dystrophy

LGMD

Limb girdle muscular dystrophy

NMD

Neuromuscular dystrophy

References

  1. 1.
    Willig TN, Bach JR, Venance V, Navaro J. Nutritional rehabilitation in neuromuscular disorders. Semin Neurol. 1995;15:18–23.CrossRefPubMedGoogle Scholar
  2. 2.
    Davidson ZE, Truby H. A review of nutrition in Duchenne muscular dystrophy. J Hum Nutr Diet. 2009;22(5):383–93.CrossRefPubMedGoogle Scholar
  3. 3.
    Bushby K, Finkel R, Birnkrant D, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2010;9(1):77–93.CrossRefPubMedGoogle Scholar
  4. 4.
    Bushby K, Finkel R, Birnkrant D, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol. 2010;9(2):177–89.CrossRefPubMedGoogle Scholar
  5. 5.
    Biggar WD, Gingraus M, Fehlings DL, et al. Deflazacort treatment of Duchenne muscular dystrophy. J Pediatr. 2001;138:45–50.CrossRefPubMedGoogle Scholar
  6. 6.
    Mendell JR, Moxley RT, Griggs RC, et al. Randomized, double-blind six-month trial of prednisone in Duchenne’s muscular dystrophy. N Engl J Med. 1989;320(24):1592–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Angelini C. The role of corticosteroids in muscular dystrophy: a critical appraisal. Muscle Nerve. 2007;36(4):424–35.CrossRefPubMedGoogle Scholar
  8. 8.
    Respiratory care of the patients with Duchenne muscular dystrophy: an official ATS consensus statement, American Thoracic Society. Am J Respir Crit Care Med. 2004;170:456–65.Google Scholar
  9. 9.
    Pichiecchio A, Uggetti C, Egitto M, et al. Quantitative MR evaluation of body composition in patients with Duchenne muscular dystrophy. Eur Radiol. 2002;12(11):2704–9.PubMedGoogle Scholar
  10. 10.
    Gonzalez Bermejo J, Lofaso F, Falaize L, et al. Resting energy expenditure in Duchenne patients using home mechanical ventilation. Eur Respir J. 2005;25(4):682–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Elliott S, Davidson Z, Davies PSW, Truby H. Predicting resting energy expenditure in boys with Duchenne muscular dystrophy. Eur J Paediatr Neurol. 2012;16(6):631–5.CrossRefPubMedGoogle Scholar
  12. 12.
    Zanardi MC, Tagliabue A, Orcesi S, Berardinelli A, Uggetti C, Pichiecchio A. Body composition and energy expenditure in Duchenne muscular dystrophy. Eur J Clin Nutr. 2003;57(2):273–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Satomura S, Yokota I, Tatara K, Naito E, Ito M, Kuroda Y. Paradoxical weight loss with extra energy expenditure at brown adipose tissue in adolescent patients with Duchenne muscular dystrophy. Metab Clin Exp. 2001;50(10):1181–5.CrossRefPubMedGoogle Scholar
  14. 14.
    Hankard R, Gottrand F, Turck D, Carpentier A, Romon M, Farriaux JP. Resting energy expenditure and energy substrate utilization in children with Duchenne muscular dystrophy. Pediatr Res. 1996;40(1):29–33.CrossRefPubMedGoogle Scholar
  15. 15.
    Okada K, Manabe S, Sakamoto S, Ohnaka M, Niiyama Y. Protein and energy metabolism in patients with progressive muscular dystrophy. J Nutr Sci Vitaminol. 1992;38(2):141–54.CrossRefPubMedGoogle Scholar
  16. 16.
    Pearlman J, Fielding R. Creatine monohydrate as a therapeutic aid in muscular dystrophy. Nutr Rev. 2006;64(2):80–8.CrossRefPubMedGoogle Scholar
  17. 17.
    Passaquin A, Renard M, Kay L, et al. Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice. Neuromuscul Disord. 2002;12(2):174–82.CrossRefPubMedGoogle Scholar
  18. 18.
    Escolar DM, Buyse G, Henricson E, et al. CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy. Ann Neurol. 2005;58(1):151–5.CrossRefPubMedGoogle Scholar
  19. 19.
    Kley RA, Tarnopolsky MA, Vorgerd M. Creatine for treating muscle disorders. Cochrane Database Syst Rev. 2011;2, CD004760.PubMedGoogle Scholar
  20. 20.
    Tarnopolsky MA, Mahoney DJ, Vajsar J, et al. Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy. Neurology. 2004;62(10):1771–7.CrossRefPubMedGoogle Scholar
  21. 21.
    Pane M, Vasta I, Messina S, et al. Feeding problems and weight gain in Duchenne muscular dystrophy. Eur J Paediatr Neurol. 2006;10(5–6):231–6.CrossRefPubMedGoogle Scholar
  22. 22.
    Aloysius A, Born P, Kinali M, Davis T, Pane M, Mercuri E. Swallowing difficulties in Duchenne muscular dystrophy: indications for feeding assessment and outcome of videofluroscopic swallow studies. Eur J Paediatr Neurol. 2008;12(3):239–45.CrossRefPubMedGoogle Scholar
  23. 23.
    Borrelli O, Salvia G, Mancini V, et al. Evolution of gastric electrical features and gastric emptying in children with Duchenne and Becker muscular dystrophy. Am J Gastroenterol. 2005;100(3):695–702.CrossRefPubMedGoogle Scholar
  24. 24.
    Seguy D, Michaud L, Guimber D, et al. Efficacy and tolerance of gastrostomy feeding in pediatric forms of neuromuscular diseases. JPEN J Parenter Enteral Nutr. 2002;26(5):298–304.CrossRefPubMedGoogle Scholar
  25. 25.
    Wagner K, Lechtzin N, Judge D. Current treatment of adult Duchenne muscular dystrophy. Biochim Biophys Acta. 2007;1772(2):229–37.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2014

Authors and Affiliations

  1. 1.Rush University Medical CenterChicagoUSA
  2. 2.Rush Children’s HospitalRush University Medical CenterChicagoUSA

Personalised recommendations